vs
Side-by-side financial comparison of Opus Genetics, Inc. (IRD) and INTERLINK ELECTRONICS INC (LINK). Click either name above to swap in a different company.
Opus Genetics, Inc. is the larger business by last-quarter revenue ($3.9M vs $2.9M, roughly 1.4× INTERLINK ELECTRONICS INC). On growth, INTERLINK ELECTRONICS INC posted the faster year-over-year revenue change (-4.5% vs -10.2%). Over the past eight quarters, Opus Genetics, Inc.'s revenue compounded faster (50.3% CAGR vs -4.4%).
Opus Genetics, Inc. is a clinical-stage biotechnology company specializing in the development of targeted gene therapies for inherited retinal diseases. It focuses on addressing unmet medical needs for patients living with rare, vision-threatening ocular conditions, with operations centered on advancing accessible therapeutic candidates for global rare disease patient populations.
Interlink Electronics, Inc. is a technology company that specializes in manufacturing sensors that are used in electronic portable devices, such as smartphones, GPS systems, and in industrial computers and systems controls.
IRD vs LINK — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $3.9M | $2.9M |
| Net Profit | — | $-574.0K |
| Gross Margin | — | 31.7% |
| Operating Margin | — | -25.7% |
| Net Margin | — | -20.1% |
| Revenue YoY | -10.2% | -4.5% |
| Net Profit YoY | 53.0% | -39.0% |
| EPS (diluted) | — | $-0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $3.9M | $2.9M | ||
| Q3 25 | $3.1M | $3.0M | ||
| Q2 25 | $2.9M | $3.4M | ||
| Q1 25 | $4.4M | $2.7M | ||
| Q4 24 | $4.3M | $3.0M | ||
| Q3 24 | $3.9M | $2.7M | ||
| Q2 24 | $1.1M | $2.9M | ||
| Q1 24 | $1.7M | $3.1M |
| Q4 25 | — | $-574.0K | ||
| Q3 25 | $-17.5M | $-336.0K | ||
| Q2 25 | $-7.4M | $100.0K | ||
| Q1 25 | $-8.2M | $-805.0K | ||
| Q4 24 | — | $-413.0K | ||
| Q3 24 | $-7.5M | $-523.0K | ||
| Q2 24 | $-7.8M | $-307.0K | ||
| Q1 24 | $-7.1M | $-741.0K |
| Q4 25 | — | 31.7% | ||
| Q3 25 | — | 41.8% | ||
| Q2 25 | — | 45.0% | ||
| Q1 25 | — | 35.6% | ||
| Q4 24 | — | 39.6% | ||
| Q3 24 | — | 41.4% | ||
| Q2 24 | — | 45.0% | ||
| Q1 24 | — | 40.1% |
| Q4 25 | — | -25.7% | ||
| Q3 25 | -269.9% | -10.6% | ||
| Q2 25 | -309.0% | 1.9% | ||
| Q1 25 | -227.2% | -31.9% | ||
| Q4 24 | — | -17.1% | ||
| Q3 24 | -207.1% | -17.8% | ||
| Q2 24 | -748.9% | -10.8% | ||
| Q1 24 | -450.5% | -24.0% |
| Q4 25 | — | -20.1% | ||
| Q3 25 | -566.9% | -11.4% | ||
| Q2 25 | -257.5% | 2.9% | ||
| Q1 25 | -187.5% | -30.2% | ||
| Q4 24 | — | -13.8% | ||
| Q3 24 | -194.6% | -19.6% | ||
| Q2 24 | -698.3% | -10.6% | ||
| Q1 24 | -415.3% | -23.7% |
| Q4 25 | — | $-0.01 | ||
| Q3 25 | $-0.25 | $-0.03 | ||
| Q2 25 | $-0.12 | $0.00 | ||
| Q1 25 | $-0.24 | $-0.09 | ||
| Q4 24 | — | $0.01 | ||
| Q3 24 | $-0.29 | $-0.04 | ||
| Q2 24 | $-0.30 | $-0.04 | ||
| Q1 24 | $-0.29 | $-0.09 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $45.1M | $2.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $15.3M | $9.2M |
| Total Assets | $50.2M | $11.7M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $45.1M | $2.7M | ||
| Q3 25 | $30.8M | $3.0M | ||
| Q2 25 | $32.4M | $2.3M | ||
| Q1 25 | $41.8M | $2.6M | ||
| Q4 24 | $30.3M | $3.0M | ||
| Q3 24 | $36.6M | $3.8M | ||
| Q2 24 | $41.4M | $4.0M | ||
| Q1 24 | $47.2M | $4.4M |
| Q4 25 | $15.3M | $9.2M | ||
| Q3 25 | $6.0M | $9.6M | ||
| Q2 25 | $17.5M | $10.0M | ||
| Q1 25 | $5.1M | $9.8M | ||
| Q4 24 | $6.7M | $10.5M | ||
| Q3 24 | $34.3M | $11.5M | ||
| Q2 24 | $40.6M | $11.7M | ||
| Q1 24 | $46.1M | $12.1M |
| Q4 25 | $50.2M | $11.7M | ||
| Q3 25 | $36.1M | $12.1M | ||
| Q2 25 | $38.7M | $12.5M | ||
| Q1 25 | $48.2M | $12.5M | ||
| Q4 24 | $36.9M | $13.1M | ||
| Q3 24 | $40.4M | $14.1M | ||
| Q2 24 | $44.8M | $14.2M | ||
| Q1 24 | $51.8M | $14.5M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-35.3M | $-356.0K |
| Free Cash FlowOCF − Capex | — | $-375.0K |
| FCF MarginFCF / Revenue | — | -13.1% |
| Capex IntensityCapex / Revenue | — | 0.7% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-168.0K |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-35.3M | $-356.0K | ||
| Q3 25 | $-6.2M | $653.0K | ||
| Q2 25 | $-10.3M | $-138.0K | ||
| Q1 25 | $-9.0M | $-271.0K | ||
| Q4 24 | $-25.6M | $-223.0K | ||
| Q3 24 | $-5.1M | $-68.0K | ||
| Q2 24 | $-7.3M | $-298.0K | ||
| Q1 24 | $-5.7M | $222.0K |
| Q4 25 | — | $-375.0K | ||
| Q3 25 | — | $650.0K | ||
| Q2 25 | — | $-143.0K | ||
| Q1 25 | — | $-300.0K | ||
| Q4 24 | — | $-293.0K | ||
| Q3 24 | — | $-155.0K | ||
| Q2 24 | — | $-300.0K | ||
| Q1 24 | — | $204.0K |
| Q4 25 | — | -13.1% | ||
| Q3 25 | — | 22.0% | ||
| Q2 25 | — | -4.2% | ||
| Q1 25 | — | -11.3% | ||
| Q4 24 | — | -9.8% | ||
| Q3 24 | — | -5.8% | ||
| Q2 24 | — | -10.4% | ||
| Q1 24 | — | 6.5% |
| Q4 25 | — | 0.7% | ||
| Q3 25 | — | 0.1% | ||
| Q2 25 | — | 0.1% | ||
| Q1 25 | — | 1.1% | ||
| Q4 24 | — | 2.3% | ||
| Q3 24 | — | 3.3% | ||
| Q2 24 | — | 0.1% | ||
| Q1 24 | — | 0.6% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -1.38× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IRD
Segment breakdown not available.
LINK
| Transferred At Point In Time | $2.7M | 94% |
| Other | $185.0K | 6% |
